Predicting Visual Outcome After Treatment of Pituitary Adenomas With Optical Coherence Tomography

American Journal of Ophthalmology

Volumn 147, Issue 1, 2009, Pages

  Jacob, Maud ^a,e   Raverot, Gérald ^a,c,e   Jouanneau, Emmanuel ^a,c,e   Borson Chazot, Françoise ^a,c,e   Perrin, Gilles ^a,e   Rabilloud, Muriel ^b,d,e   Tilikete, Caroline ^a,c,e   Bernard, Martine ^a,e   Vighetto, Alain ^a,c,e  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; HUMAN; HYPOPHYSIS ADENOMA; OPTICAL COHERENCE TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROLACTINOMA; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; VISION;

EID: 57649130975     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.07.016     Document Type: Article

References (27)

1. Cohen A.R., Cooper P.R., Kupersmith M.J., Flamm E.S., and Ransohoff J. Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery 17 (1985) 446-452
2. Gnanalingham K.K., Bhattacharjee S., Pennington R., Ng J., and Mendoza N. The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry 76 (2005) 415-419
3. Marcus M., Vitale S., Calvert P.C., and Miller N.R. Visual parameters in patients with pituitary adenoma before and after transsphenoidal surgery. Aust N Z J Ophthalmol 19 (1991) 111-118
4. Sullivan L.J., O'Day J., and McNeill P. Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968-1987. J Clin Neuroophthalmol 11 (1991) 262-267
5. Findlay G., McFadzean R.M., and Teasdale G. Recovery of vision following treatment of pituitary tumors; application of a new system of assessment to patients treated by transsphenoidal operation. Acta Neurochir (Wien) 68 (1983) 175-186
6. Lennerstrand G. Visual recovery after treatment for pituitary adenoma. Acta Ophthalmol (Copenh) 61 (1983) 1104-1117
7. Trautmann J.C., and Laws Jr. E.R. Visual status after transsphenoidal surgery at the Mayo Clinic, 1971-1982. Am J Ophthalmol 96 (1983) 200-208
8. Parmar D.N., Sofat A., Bowman R., Bartlett J.R., and Holder G.E. Visual prognostic value of the pattern electroretinogram in chiasmal compression. Br J Ophthalmol 84 (2000) 1024-1026
9. Budenz D.L., Chang R.T., Huang X., Knighton R.W., and Tielsch J.M. Reproducibility of retinal nerve fiber thickness measurements using the stratus OCT in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 46 (2005) 2440-2443
10. Blumenthal E.Z., Williams J.M., Weinreb R.N., Girkin C.A., Berry C.C., and Zangwill L.M. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology 107 (2000) 2278-2282
11. Paunescu L.A., Schuman J.S., Price L.L., et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCT. Invest Ophthalmol Vis Sci 45 (2004) 1716-1724
12. Monteiro M.L., Leal B.C., Rosa A.A., and Bronstein M.D. Optical coherence tomography analysis of axonal loss in band atrophy of the optic nerve. Br J Ophthalmol 88 (2004) 896-899
13. Kanamori A., Nakamura M., Matsui N., et al. Optical coherence tomography detects characteristic retinal nerve fiber layer thickness corresponding to band atrophy of the optic discs. Ophthalmology 111 (2004) 2278-2283
14. Leal B.C., Moura F.C., and Monteiro M.L. Retinal nerve fiber layer loss documented by Stratus OCT in patients with pituitary adenoma: case report. Arq Bras Oftalmol 69 (2006) 251-254
15. Monteiro M.L., Moura F.C., and Medeiros F.A. Diagnostic ability of optical coherence tomography with a normative database to detect band atrophy of the optic nerve. Am J Ophthalmol 143 (2007) 896-899
16. Monteiro M.L., Leal B.C., Moura F.C., Vessani R.M., and Medeiros F.A. Comparison of retinal nerve fibre layer measurements using optical coherence tomography versions 1 and three in eyes with band atrophy of the optic nerve and normal controls. Eye 21 (2007) 16-22
17. Danesh-Meyer H.V., Papchenko T.L., Savino P.J., Law A., Evans J., and Gamble G.D. In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci (2008) Forthcoming
18. Chauhan B.C., and Johnson C.A. Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects. Invest Ophthalmol Vis Sci 40 (1999) 648-656
19. Henson D.B., Chaudry S., Artes P.H., Faragher E.B., and Ansons A. Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes. Invest Ophthalmol Vis Sci 41 (2000) 417-421
20. Mikelberg F.S., Drance S.M., Schulzer M., Yidegiligne H.M., and Weis M.M. The normal human optic nerve. Axon count and axon diameter distribution. Ophthalmology 96 (1989) 1325-1328
21. Alamouti B., and Funk J. Retinal thickness decreases with age: an OCT study. Br J Ophthalmol 87 (2003) 899-901
22. Varma R., Bazzaz S., and Lai M. Optical tomography-measured retinal nerve fiber layer thickness in normal Latinos. Invest Ophthalmol Vis Sci 44 (2003) 3369-3373
23. Kanamori A., Escano M.F., Eno A., et al. Evaluation of the effect of aging on retinal nerve fiber layer thickness measured by optical coherence tomography. Ophthalmologica 217 (2003) 273-278
24. Mok K.H., Lee V.W., and So K.F. Retinal nerve fiber layer measurement of the Hong Kong Chinese population by optical coherence tomography. J Glaucoma 11 (2002) 481-483
25. Mikelberg F.S., and Yidegiligne H.M. Axonal loss in band atrophy of the optic nerve in craniopharyngioma: a quantitative analysis. Can J Ophthalmol 28 (1993) 69-71
26. Quigley H.A., Addicks E.M., and Green W.R. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 100 (1982) 135-146
27. Kerrison J.B., Lynn M.J., Baer C.A., Newman S.A., Biousse V., and Newman N.J. Stages of improvement in visual fields after pituitary tumor resection. Am J Ophthalmol 130 (2000) 813-820